Michael A. Kelly Appointed to DMC Global’s Board of Directors
July 27 2020 - 9:00AM
DMC Global Inc. (Nasdaq: BOOM) today announced its board of
directors has elected Michael A. Kelly as an independent director.
Mr. Kelly joins the DMC board with an extensive
background in finance, operations and information systems
management. He is president of Sentry Hill Partners, LLC, a
global life sciences transformation and management consulting
business founded by Mr. Kelly in 2018.
He previously spent 14 years in senior and
executive leadership positions with Amgen Inc., one of the world’s
largest independent biotechnology companies. From 2014 to
2017, he was senior vice president of Amgen’s Global Business
Services division, where he led more than 1,000 employees and
oversaw a successful transformation and expansion of the
organization’s business model.
Mr. Kelly twice served as Amgen’s acting
CFO. He also was vice president of multiple domestic and
international business units. As vice president of commercial
operations, he led the transition team following Amgen’s $9.7
billion acquisition of Onyx Pharmaceuticals in 2013. He also
led the creation and integration of a $1.4 billion joint venture
between Amgen and Tokyo-based Astellas Pharma. As vice
president and CFO of Amgen’s international commercial operations,
Mr. Kelly developed and executed a strategy to expand the company’s
emerging markets footprint. His efforts included acquisitions
in Turkey and Brazil that collectively added more than $400 million
in sales and nearly 2,000 employees.
From 2000 to 2003, Mr. Kelly was CFO of publicly
traded TANOX, Inc. He also held financial leadership positions with
BIOGEN, Inc., and NutraSweet Kelco Company, a subsidiary of
Monsanto Life Sciences.
Kevin Longe, president, CEO and director of DMC,
said, “Michael is widely regarded as a talented and innovative
executive, and we are honored he has joined the DMC board.
His extensive experience managing and growing domestic and
international organizations, as well as his track record in
finance, operations and building differentiated product companies,
aligns well with DMC’s business model, and will be highly valuable
as we continue the pursuit of our long-term growth strategy.
We look forward to his insight and contributions.”
Mr. Kelly said, “DMC has achieved an impressive
record of innovation and growth, and also has established a
compelling long-term strategy for increasing stakeholder
value. I look forward to working with the board to support
DMC’s leadership team as it pursues its growth and sustainability
objectives.”
Mr. Kelly received a Bachelor of Science degree
in business administration from Florida A&M University. He is
an independent member of the board of directors for publicly traded
Hookipa Pharma, Inc., where he also is the audit committee
chairman. Mr. Kelly serves on the Council of Advisors and was the
former audit committee chairman for Direct Relief, a humanitarian
aid organization active in all 50 U.S. states, and more than 80
countries. The charity seeks to improve the health and lives
of people affected by poverty or emergencies.
About DMC GlobalDMC Global is a
diversified holding company. Our innovative businesses
provide differentiated products and services to niche industrial
and commercial markets around the world. DMC’s objective is to
identify well-run businesses and strong management teams and
support them with long-term capital and strategic, legal,
technology and operating resources. Our approach helps our
portfolio companies grow core businesses, launch new initiatives,
upgrade technologies and systems to support their long-term
strategy, and make acquisitions that improve their competitive
positions and expand their markets. DMC’s culture is to
foster local innovation versus centralized control, and stand
behind our businesses in ways that truly add value. Today, DMC’s
portfolio consists of DynaEnergetics and NobelClad, which
collectively address the energy, industrial processing and
transportation markets. Based in Broomfield, Colorado, DMC
trades on Nasdaq under the symbol “BOOM.” For more information,
visit the Company’s website at: http://www.dmcglobal.com.
CONTACT:
Geoff HighVice President of Investor Relations303-604-3924
DMC Global (NASDAQ:BOOM)
Historical Stock Chart
From Sep 2024 to Oct 2024
DMC Global (NASDAQ:BOOM)
Historical Stock Chart
From Oct 2023 to Oct 2024